Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie
Not yet recruitingOBSERVATIONAL
Enrollment
133
Participants
Timeline
Start Date
April 24, 2025
Primary Completion Date
April 24, 2027
Study Completion Date
April 30, 2027
Conditions
Metastatic Colorectal Cancer
All Listed Sponsors
lead
Libbs Farmacêutica LTDA
INDUSTRY
NCT06808685 - Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie | Biotech Hunter | Biotech Hunter